… Therefore, restoring the SARS-CoV-2-induced RAS imbalance has been suggested as
an ideal clinical approach to slow the early progression of COVID-19 pathogenesis. …

… Our proposed strategies for targeting ACE2 in COVID-19 therapy are illustrated in Figure 2.
… In conclusion, ACE2 targeting is an underexplored approach to COVID-19 therapeutics and …

… We compared three approaches for defining recovery following a COVID-19 hospitalization:
… days at home (Therapeutics for Inpatients with COVID-19 [TICO] approach), and 3) recovery …

… , a large number of possible pharmaceutical approaches for … candidate therapeutics
have borne out during COVID-19. … Therefore, one potential approach to reducing COVID-19 …

… the design of COVID-19 specific therapeutics and vaccines … of these prophylactic and
therapeutic approaches. This Review … -mediated approaches currently explored for COVID-19 …

… situations and discusses the proteomics approach towards the COVID-19 dilemma. … therapy
for severe patients remains hypothetical, largely due to limited understanding of COVID 19 …

… in treating severe COVID-19 presentations due to … COVID-19 pathogenesis, respective
areas where cell therapies have potential, and the ongoing 89 cell therapy trials in COVID-19 as …

… ics tools and a systems biology approach [16]. The obtained results will be validated
through a literature review on SARS, MERS, and COVID-19 to indicate how the IFNmediated …

… COVID-19 and novel exosome-based therapeutics … COVID-19. We also highlight the
potential roles of exosomes as novel anti-inflammatory therapeutics for the treatment of COVID-19. …

… article is to provide a brief collective overview of the recent status of therapeutics advances
and approaches, and their current state of implementation for the management of COVID-19. …